Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

OBJECTIVE: The aim of this study was to compare the incidence of cancer and all-cause and cause-specific mortality rates among a cohort of patients with severe PsA receiving TNF inhibitor (TNFi) with those of the general UK population. METHODS: Cancers and deaths were identified from the national ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatology (Oxford)
Hlavní autoři: Fagerli, Karen M, Kearsley-Fleet, Lianne, Mercer, Louise K, Watson, Kath, Packham, Jon, Symmons, Deborah P M, Hyrich, Kimme L
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Clinical Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6293477/
https://ncbi.nlm.nih.gov/pubmed/30137485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/key241
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky